Summary &mdash; Crude propolis and commercial products containing propolis, such as ethanolic extracts, tablets, capsules and powders acquired in São Paulo City (Brazil) were analyzed. The resins of the solid products were extracted with ethanol and found to be present at various concentrations, independently of the propolis concentration specified on the label of the commercial products. The in vitro activity of these resins against S aureus, B cereus and B subtilis was also determined. The results showed that the antibacterial activity rather than the propolis concentration itself should be considered for quality control and that some resins are likely to display a species-specific action.
INTRODUCTION
Propolis (bee glue) has been used in folk medicine for centuries (Ghisalberti, 1979) . This is supported by recent findings about its biological properties such as antibacterial (Grange and Davey, 1990) , antiviral (Amoros et al, 1992) or anti-protozoan (Starzyk et al, 1977) activity, inhibition of tumor processes (Frenkel et al, 1993) , antiinflammatory action (Dobowolski et al, 1991; Volpert and Elstner, 1996) , induction of both bone (Stojko et al, 1979) and cartilaginous tissue regeneration , free radical scavenging (Scheller et al, 1989; Volpert and Elstner, 1993) , and allergenic effect (Hausen et al, 1987a, b; Ginanneschi et al, 1989) . The biological properties and chemical composition of propolis have been recently reviewed (Marcucci, 1995) .
The characterization of these biological properties together with the current trend towards utilizing natural products have resulted in an increased demand for propo-lis and products containing propolis, such as ethanol extracts, tablets, capsules, sprays, or powders.
The expansion of the propolis industry requires standardization of these products, and should take into account regional vegetation diversity (Vanhaelen and Vanhaelen-Fastré, 1979) , the harvesting activity of distinct races of honeybees (Singh, 1972) , and establish the efficacy of the products.
In addition, such a standardization needs to be simple and inexpensive to be accessible to manufacturers.
In this context, the objective of the present study was the evaluation of the in vitro antibacterial activity of the different formulations of propolis. Samples were bought in pharmacies, drugstores and from beekeepers.
MATERIALS AND METHODS
Propolis and commercial products containing propolis (Ackermann, 1991 (Haiji and FkihTetouani, 1993 ). In addition, inadequate storage could also result in a propolis with high resin content, but low antibacterial activity.
Inactivation of antibacterial compounds during the manufacturing process and utilization of low quality propolis are some of the possible reasons for the low antibacterial activity of the capsule, tablet and powder but our data is too limited to form a definitive conclusion. Since we had no information on the industrial procedures, nor on the phytogeographic origin of the propolis contained in the commercial products, we were unable to determine which of these possibilities was the most significant. On the other hand, the high activity of powdered propolis resin against only B cereus (table II) indicates that this resin may have speciesspecific action.
The present findings indicate that the antibacterial activity, and perhaps other biological properties of propolis, could not be correlated with their resin concentration but mostly with their chemical composition, which can be variable according to the collection site (Tomas-Barberán et al, 1993) and the quality of the resin. Therefore the methodology used was effective in the evaluation of the quality of antibacterial activity from both propolis and commercial products containing propolis. 
